NDC 43074-112

Diabecline

Tetracycline Hydrochloride

Diabecline is a Topical Ointment in the Human Otc Drug category. It is labeled and distributed by Phillips Company. The primary component is Tetracycline Hydrochloride.

Product ID43074-112_f934f64d-4fc0-4344-85fa-51312257a591
NDC43074-112
Product TypeHuman Otc Drug
Proprietary NameDiabecline
Generic NameTetracycline Hydrochloride
Dosage FormOintment
Route of AdministrationTOPICAL
Marketing Start Date2013-06-10
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart333B
Labeler NamePhillips Company
Substance NameTETRACYCLINE HYDROCHLORIDE
Active Ingredient Strength30 mg/g
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 43074-112-11

3 g in 1 BOTTLE (43074-112-11)
Marketing Start Date2013-06-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43074-112-12 [43074011212]

Diabecline OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart333B
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-06-10
Marketing End Date2013-06-12

NDC 43074-112-11 [43074011211]

Diabecline OINTMENT
Marketing CategoryOTC monograph final
Application Numberpart333B
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-06-10
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
TETRACYCLINE HYDROCHLORIDE30 mg/g

OpenFDA Data

SPL SET ID:3d858754-b3d0-49cb-834e-9b9a35eea0fa
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1542815
  • 1542813

    • NDC Crossover Matching brand name "Diabecline" or generic name "Tetracycline Hydrochloride"

    NDCBrand NameGeneric Name
    24471-200DiabeclineTetracycline hydrochloride
    43074-112DiabeclineTETRACYCLINE HYDROCHLORIDE
    43074-116AcnecyclineTETRACYCLINE HYDROCHLORIDE
    43074-108DyabetexTETRACYCLINE HYDROCHLORIDE
    49884-732SUMYCINTetracycline Hydrochloride
    49884-733SUMYCINTetracycline Hydrochloride
    43074-103TETRA-ABCTETRACYCLINE HYDROCHLORIDE
    0440-8505Tetracycline HydrochlorideTetracycline Hydrochloride
    0591-2474Tetracycline HydrochlorideTetracycline Hydrochloride
    0591-2475Tetracycline HydrochlorideTetracycline Hydrochloride
    10544-590Tetracycline HydrochlorideTetracycline Hydrochloride
    21695-302Tetracycline HydrochlorideTetracycline Hydrochloride
    21695-640Tetracycline HydrochlorideTetracycline Hydrochloride
    23155-017tetracycline hydrochloridetetracycline hydrochloride
    23155-018tetracycline hydrochloridetetracycline hydrochloride
    23155-766Tetracycline HydrochlorideTetracycline Hydrochloride
    23155-767Tetracycline HydrochlorideTetracycline Hydrochloride
    42291-798Tetracycline HydrochlorideTetracycline Hydrochloride
    42291-799Tetracycline HydrochlorideTetracycline Hydrochloride
    47781-508Tetracycline HydrochlorideTetracycline Hydrochloride
    47781-509Tetracycline HydrochlorideTetracycline Hydrochloride
    51991-906Tetracycline HydrochlorideTetracycline Hydrochloride
    51991-907Tetracycline HydrochlorideTetracycline Hydrochloride
    52959-336Tetracycline HydrochlorideTetracycline Hydrochloride
    53808-0877Tetracycline HydrochlorideTetracycline Hydrochloride
    60219-1522Tetracycline HydrochlorideTetracycline Hydrochloride
    60219-1523Tetracycline HydrochlorideTetracycline Hydrochloride
    62135-225Tetracycline Hydrochloridetetracycline hydrochloride
    43074-115Tetracycline-ABCTETRACYCLINE HYDROCHLORIDE
    43074-301TetraStemTETRACYCLINE HYDROCHLORIDE

    Trademark Results [Diabecline]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DIABECLINE
    DIABECLINE
    85282467 4085214 Dead/Cancelled
    THRU PHARMA, LLC
    2011-03-31
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.